newsfilter
← Latest News
FDA Approved Drugs·

Approval of IRBESARTAN, ANDA #203071 (Labeling)

Approval Date: 11/04/2026 Drug Name: IRBESARTAN, ANDA #203071 Submission: SUPPL-12 Active Ingredients: IRBESARTAN Company: PRINSTON INC Submission Status: Approval Submission Classification: Labeling Application Number: 203071

Company
PRINSTON INC
Keywords
IRBESARTAN